Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599765 · ClinicalTrials.gov registry record · Phase 2
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
A Phase 2 study of Oligometastatic Malignant Solid Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 380
- Enrollment target
- 12
- Study locations
NCT03599765: Active Phase 2 study of Oligometastatic Malignant Solid Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT03599765 is a Phase 2 study of Oligometastatic Malignant Solid Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 380 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher). The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599765, a Phase 2 study of Oligometastatic Malignant Solid Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 380 participants
- Enrollment target
- 12
- Study locations
Study Summary
This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body. Treatment with up-front local consolidative therapy may be better in helping to control the disease.
Primary Outcome
General descriptive statistics will be computed.
Conditions Studied
Interventions
- OTHER Best Practice
- PROCEDURE Local Consolidation Therapy
Study Locations (12)
Texas
- M D Anderson Cancer Center - Houston
- MD Anderson in Katy - Houston
- MD Anderson League City - Nassau Bay
- University of Texas Health Science Center at San Antonio - San Antonio
- MD Anderson in Sugar Land - Sugar Land
- MD Anderson in The Woodlands - The Woodlands
Arizona
- Banner MD Anderson Cancer Center - Gilbert
Arkansas
- Baptist Health Medical Center - Little Rock
Hawaii
- Queen's Medical Center - Honolulu
Michigan
- Community Health Center - Coldwater
New Jersey
- Cooper Hospital University Medical Center - Camden
Ohio
- OhioHealth Mansfield Hospital - Mansfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 2 |
What the registry record for NCT03599765 still lists
NCT03599765 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher).
The record links to 1 condition, with Oligometastatic Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Best Practice is the first listed.
NCT03599765 lists 12 locations in 7 states (Texas, Arizona, Arkansas).
Frequently Asked Questions
What is clinical trial NCT03599765 about?
NCT03599765 is a clinical study titled "Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor". This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body. Treatment with up-front local consolidative therapy may be better in helping to control the disease.
What is the current status of trial NCT03599765?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 380 participants. The study started on 2018-07-31. Estimated completion is 2029-12-31.
What conditions does trial NCT03599765 study?
This clinical trial studies the following conditions: Oligometastatic Malignant Solid Neoplasm.
What interventions are being tested in trial NCT03599765?
The interventions under investigation include: Best Practice (OTHER), Local Consolidation Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT03599765?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03599765 being conducted?
This trial has 12 study locations across Arizona, Arkansas, Hawaii, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oligometastatic Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03599765's enrollment target sits among peer trials
380 111th of 2000 higher than 1,886 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI